Official Title
Genes Involved in Lipid Disorders
Brief Title
Genes Involved in Lipid Disorders
Protocol ID
NCT02311335
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Brief Summary
Background:
- Genes are the instructions our body uses to function. Researchers can look for changes,
or variants, in the genes. The goal of this study is to find new gene changes that lead
to lipid disorders. Older research methods looked at one or a few genes at a time.
Genomic sequencing looks at most of the genes at once. Genomic sequencing may find the
cause researchers haven t been able to find from past methods.
Objectives:
- To better understand genetic causes of lipid disorders through genomic sequencing.
Eligibility:
- People age 2 and older with unusual lipid disorders, and their relatives.
Design:
- Participants will be screened with a physical exam and medical history. They will
have blood taken. They may give a saliva sample.
- Based on the screening test, researchers will chose 3-5 family members to perform
the genomic sequencing. The sequencing will be done on a sample of DNA collected
during the blood draw and saliva sample.
- Participants may be invited to take part in other protocols that may involve imaging
of their heart or blood vessels. They do not have to participate. If they do, they
will sign a separate consent for those tests.
- If a participant s family member cannot travel to the NIH, the NIH documents and
consent will be reviewed during a teleconference. A blood or sputum kit will be
mailed to them.
Detailed Description
The primary purpose of this discovery protocol is to identify new lipid genes from
subjects with rare genetic lipids disorders. We will take advantage of the new technology
of whole exome sequencing to find the cause of dyslipidemia that we haven t been able to
find using past methods. We will work with geneticists to review the sequence data for
unexpected gene changes (incidental findings) that do not explain the lipid disorder but
gene changes that can cause medical disorders such as rare forms of cancer or heart
disease. The opportunity to participate in the Clinical Center Genomics Opportunity
(CCGO) program will enable us to take advantage of our expertise in other rare lipid
disorders and translate this knowledge into new diagnostics and therapies, which is a key
mission of the NIH.
Study Period
-
Enrollment Count
140 participants
Eligibility Criteria
- INCLUSION CRITERIA:
Index cases to be included are those with unusual dyslipidemia. Relatives of affected
individuals may also be included as appropriate.
Child Index: greater than or equal to 2 years older
Adult Index: greater than or equal to18 years older
Child relatives (siblings, cousins): greater than or equal to 2 years older
Adult Relative: greater than or equal to18 years older
(Biological parent, aunt, uncle or grandparent)
EXCLUSION CRITERIA:
1. Inability or unwillingness to provide informed consent or assent
2. Prisoners or other institutionalized persons will not be allowed to participate.
3. Children <2 years of age.
Filters
Lipid Disorders
COMPLETED
CHILD
ADULT
OLDER_ADULT